Skip to content

Clinical trials

Fabry Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Country / region: Germany Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20071
20081
20103
20112
20121
20141
20151
20161
20172
20183
20192
20202
20213
20222
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting5
Recruiting5
Terminated3
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock5
Idorsia Pharmaceuticals Ltd.3
Shire3
Wuerzburg University Hospital3
Sangamo Therapeutics2
Sanofi2
Spur Therapeutics2
Amicus Therapeutics1
Chiesi Farmaceutici S.p.A.1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease31
Stroke5
Lysosomal Storage Diseases4
Rare Diseases3
Angiokeratoma2
Cardiomyopathy, Hypertrophic2
Renal Insufficiency, Chronic2
Fibrosis1
Hearing Loss1
Mucopolysaccharidoses1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.